Alpha-chain disease.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic; D003520:Cyclophosphamide / Q000627:therapeutic use; D006362:Heavy Chain Disease / Q000175:diagnosis / Q000276:immunology / Q000473:pathology; D006801:Humans; D007070:Immunoglobulin A / Q000378:metabolism; D007143:Immunoglobulin Heavy Chains; D007137:Immunoglobulin alpha-Chains / Q000032:analysis; D008223:Lymphoma / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous
D000900:Anti-Bacterial Agents; D007070:Immunoglobulin A; D007143:Immunoglobulin Heavy Chains; D007137:Immunoglobulin alpha-Chains; D003520:Cyclophosphamide; D011241:Prednisone